Commonwealth Equity Services LLC lifted its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 5.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 277,208 shares of the company's stock after purchasing an additional 14,882 shares during the quarter. Commonwealth Equity Services LLC's holdings in Kenvue were worth $5,918,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Handelsbanken Fonder AB grew its holdings in Kenvue by 2.9% in the 4th quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company's stock valued at $15,846,000 after buying an additional 21,222 shares in the last quarter. Alberta Investment Management Corp increased its position in Kenvue by 23.2% in the 4th quarter. Alberta Investment Management Corp now owns 582,895 shares of the company's stock valued at $12,445,000 after acquiring an additional 109,700 shares during the period. Longbow Finance SA increased its holdings in Kenvue by 5.0% in the fourth quarter. Longbow Finance SA now owns 280,568 shares of the company's stock valued at $5,990,000 after purchasing an additional 13,287 shares during the period. Steward Partners Investment Advisory LLC raised its position in Kenvue by 143.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company's stock worth $1,023,000 after purchasing an additional 28,216 shares during the last quarter. Finally, CORDA Investment Management LLC. grew its position in shares of Kenvue by 1.4% in the 4th quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company's stock valued at $26,754,000 after buying an additional 17,466 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several analysts have recently commented on the stock. Evercore ISI started coverage on shares of Kenvue in a research report on Monday. They set an "in-line" rating and a $25.00 price objective for the company. UBS Group dropped their price target on Kenvue from $23.00 to $21.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. Deutsche Bank Aktiengesellschaft cut Kenvue from a "buy" rating to a "hold" rating and reduced their price objective for the company from $25.00 to $24.00 in a research note on Thursday, December 12th. Barclays lowered their target price on Kenvue from $23.00 to $21.00 and set an "equal weight" rating on the stock in a research report on Friday, January 17th. Finally, Piper Sandler increased their target price on Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a report on Monday, February 24th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $23.85.
Check Out Our Latest Research Report on Kenvue
Kenvue Price Performance
KVUE stock traded up $0.30 during midday trading on Wednesday, reaching $23.40. The company had a trading volume of 9,473,245 shares, compared to its average volume of 16,138,417. The firm has a 50-day moving average price of $22.17 and a 200-day moving average price of $22.44. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $24.46. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The company has a market capitalization of $44.72 billion, a P/E ratio of 44.15, a P/E/G ratio of 2.62 and a beta of 1.25.
Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $0.26 EPS for the quarter, hitting analysts' consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.
Kenvue Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th were issued a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a yield of 3.50%. The ex-dividend date of this dividend was Wednesday, February 12th. Kenvue's dividend payout ratio (DPR) is presently 154.72%.
About Kenvue
(
Free Report)
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Read More
Before you consider Kenvue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.
While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
